0

Global Non-alcoholic Steatohepatitis Market 2016-2020

  • Published: May 2016
  • Pages: 70
  • SKU: IRTNTR8374
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

This market research report includes a detailed segmentation of the global non-alcoholic steatohepatitis market by dosage form (solid and liquid) and by route of administration (oral and parenteral). It also outlines the market shares for key regions like the Americas, APAC, and Europe. The leading vendors analyzed in this report are AstraZeneca, Arena Pharmaceuticals, GlaxoSmithKline, Novo Nordisk, Roche, and Vivus.

Outlook of the global non-alcoholic steatohepatitis market

Technavio’s market research analyst predicts the global non-alcoholic steatohepatitis (NASH) market to rapidly grow at a CAGR of approximately 24% by 2020. Much of this market’s growth can be attributed to the high prevalence of obesity and diabetes among the populace. In 2014, more than 1.9 billion adults were found to be overweight. Of these, over 600 million were obese. Similarly, in 2014, the global prevalence of diabetes in adults over 18 years of age was estimated to be 9%. High incidence of these associated conditions is the major driver for the growth of this market during the forecast period.

Furthermore, the launch of novel drug candidates with a high efficacy and safety profile will have a positive effect on the growth of this market.

Product-based segmentation of the non-alcoholic steatohepatitis drugs market

  • Oral
  • Parenteral

In this market study, analysts have estimated the oral route of drug administration to be the most preferred route of drug ingestion for the treatment of NASH. Drugs like Forxiga/Farxiga and Komboglyze are administered through this route.

The parenteral route of administration is required during emergencies, especially when there is a need for greater patient compliance. Drugs like Actrapid, Insulatard, Levemir, and Byetta are administered through this route.

Geographical segmentation of the non-alcoholic steatohepatitis drugs market

  • Americas
  • APAC
  • Europe

In this global market research, analysts have estimated the Americas to be the largest market for non-alcoholic steatohepatitis drugs during the forecast period. This region currently accounts for approximately 59% of the total market share and is envisaged to retain its hold over the market by 2020 owing to the high incidence of obesity and diabetes in regions like the US, Canada, and Brazil.

Competitive landscape and key vendors

The global non-alcoholic steatohepatitis market is highly competitive owing to the presence of numerous small and large players that operate on a local or global scale. The vendors in this market compete on the basis of price, quality, and innovation. The high level of competition in this market has led to an increase in the number of M&A, wherein smaller entities are being acquired by, or are being merged with, major players.

Leading vendors in the market are -

  • AstraZeneca
  • Arena Pharmaceuticals
  • GlaxoSmithKline
  • Novo Nordisk 
  • Roche
  • Vivus

Other prominent vendors in the market include Arisaph Pharmaceuticals, Cempra Pharmaceuticals, Galectin Therapeutics, Galmed Pharmaceuticals, Genfit, Gilead, Immuron, Interceptpharma, Raptor Pharmaceutical, Shire, Tobira Therapeutics, Verva, and Viking Therapeutics.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the global non-alcoholic steatohepatitis market?
  • What are the key market trends impacting the growth of the global non-alcoholic steatohepatitis market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the vendors in the global non-alcoholic steatohepatitis market?
  • What are the trending factors influencing the market shares of the Americas, APAC, and Europe?
  • What are the key outcomes of the five forces analysis of the global non-alcoholic steatohepatitis market?

Technavio also offers customization on reports based on specific client requirement.

Related reports

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of  the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Disease overview

  • Understanding the disease
  • Symptoms and signs
  • Pathophysiology
  • Risk factors
  • Diagnosis
  • Treatment
  • Epidemiology
  • Economic burden

PART 06: Pipeline analysis

  • Pipeline information of NASH
  • Clinical trials for NASH

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by dosage form

  • Solid
  • Liquid

PART 09: Market segmentation by route of administration

  • Oral
  • Parenteral

PART 10: Geographical segmentation

  • Global NASH drugs market by geographical segmentation 2015-2020
  • NASH drugs market in Americas
  • NASH drugs market in US
  • NASH drugs market in EMEA
  • NASH drugs market in APAC

PART 11: Market drivers

  • Increase in sedentary lifestyle
  • Prevalence of associated health conditions
  • Promising pipeline
  • Significant unmet medical needs

PART 12: Impact of drivers

PART 13: Market challenges

  • Limited understanding of disease pathophysiology
  • Insufficient diagnostic technology for NASH
  • Stringent regulatory procedure
  • Adverse effects of drugs

PART 14: Impact of drivers and challenges

PART 15: Market trends

  • Rise in public awareness
  • Increase in strategic alliances
  • Patient assistance programs
  • Usage of off-label drugs

PART 16: Vendor landscape

  • Competitive scenario
  • Arena Pharmaceuticals
  • AstraZeneca
  • F Hoffmann-La Roche
  • GSK
  • Novo Nordisk
  • Vivus
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>